Therapeutic Vaccine Prevents Pancreatic Cancer's Recurrence in 3-Year Trial
MONDAY, April 8, 2024 -- A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says.Eight patients have not had their pancreatic cancer recur... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 8, 2024 Category: General Medicine Source Type: news
Immunotherapy Before Surgery Might Boost Pancreatic Cancer Survival
MONDAY, April 8, 2024 -- Pancreatic cancer patients may do better if they receive an immunotherapy drug as well as chemotherapy in preparation for surgery, new research suggests.Pancreatic cancer is one of the toughest to treat. Only 12% of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 8, 2024 Category: General Medicine Source Type: news
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in …
Three-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran (BNT122, RO7198457) continue to show polyspecific T cell responses up to three years and delayed tumor recurrence in patients with resected pancreatic ductal…#phase1 #bnt122 #pdac #phase2 #autogene #genentechinc #genentech #rochegroup #inest #bntx (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news
UltraCon: How reliable is POCUS for pancreatic imaging?
AUSTIN, TX – Point-of-care ultrasound (POCUS) isn’t typically used for imaging the pancreas, but perhaps that should change, according to a presentation given April 7 at UltraCon.
In her talk, Alice Lee, MD, from Stanford University in California highlighted findings on how POCUS can be a reliable tool for pancreatic imaging, whether performed by experienced or novice sonographers.
“One of the big implications of pancreatic POCUS is the way that we put imaging in the hands of a provider who’s really managing the patient, whether it’s the gastroenterologist or the primary care physician,” Lee said.
Alice Lee,...
Source: AuntMinnie.com Headlines - April 7, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Gastrointestinal Radiology Source Type: news
Certain Pesticides Linked With Risk for Pancreatic Cancer Certain Pesticides Linked With Risk for Pancreatic Cancer
The incidence of pancreatic adenocarcinoma has been increasing steadily for more than 30 years.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Diabetes patients offered artificial-pancreas tech
The rollout of new devices for thousands in England with type 1 diabetes is hailed as a landmark moment. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 1, 2024 Category: Consumer Health News Source Type: news
World-first artificial pancreas roll-out will see up to 150,000 diabetics get the life-changing gadgets on the NHS
The device - known as a hybrid closed-loop system - uses a hi-tech algorithm to determine the amount of insulin needed to keep the wearer's blood sugar levels steady, which is delivered via a pump. (Source: the Mail online | Health)
Source: the Mail online | Health - April 1, 2024 Category: Consumer Health News Source Type: news
No OS Difference in Pancreatic Cancer With SABR vs Irreversible Electroporation
(MedPage Today) -- The use of either MRI-guided stereotactic ablative body radiotherapy (SABR) or CT-guided percutaneous irreversible electroporation after standard FOLFIRINOX chemotherapy did not result in any significant difference in overall... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 21, 2024 Category: Gastroenterology Source Type: news
Doctor reveals the red flag signs of 7 silent killers you might easily ignore
From pancreatic to cervical cancer, signs of seven types of the potentially deadly disease shouldn't be ignored. (Source: Daily Express - Health)
Source: Daily Express - Health - March 19, 2024 Category: Consumer Health News Source Type: news
Training technique in AI helps preserve patient privacy
The privacy of patient data in AI models trained on chest x-rays can be guaranteed – importantly, without significantly reducing the accuracy of models on large “real-world” data sets, according to a study published March 14 in Communications Medicine.
A team in Germany used an approach called “differential privacy” when training large-scale AI models and then evaluated its effects on model performance. They found high accuracy was attainable, despite the stringent privacy guarantees, noted lead authors and PhD students Soroosh Tayebi Arasteh, of University Hospital RWTH Aachen, and Alexander Ziller, of the Tech...
Source: AuntMinnie.com Headlines - March 18, 2024 Category: Radiology Authors: Will Morton Tags: CT Digital X-Ray Source Type: news
Distinctive pathology associated with focal stenosis of the main pancreatic duct secondary to remote trauma: a long-term complication of seat belt pancreatitis - Wu AA, Thompson ED, Cameron JL, He J, Burkhart RA, Burns WR, Lafaro KJ, Shubert CR, Canto MI, Fishman EK, Hruban RH.
We present fou... (Source: SafetyLit)
Source: SafetyLit - March 16, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Study Explores Safety of Removing Inoperable Pancreatic Tumors
A clinical trial will examine if chemotherapy followed by a novel surgical procedure can improve outcomes for patients with pancreatic tumors previously considered inoperable (Source: Disabled World)
Source: Disabled World - March 15, 2024 Category: Disability Tags: Pancreatic Cancer Source Type: news
Should doctors screen all kids for type 1 diabetes?
Millions worldwide live with type 1 diabetes, and for most the diagnosis came as a shock, following mysterious symptoms such as thirst and weight loss. But diabetes specialists have long known that certain blood tests can foretell the disease years earlier. That has left the field wrestling with a difficult question: Should healthy children get these blood tests, and would knowing about incipient diabetes help them?
Now, as a first wave of studies indicates such testing can
prevent life-threatening complications at diagnosis
, and with a new treatment to delay disease onset, the answers are tipping toward ...
Source: ScienceNOW - March 13, 2024 Category: Science Source Type: news
Wegovy Is Good for More Than Just Weight Loss
The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It’s the first weight-loss drug to carry an indication for heart benefits.
The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo.
[time-brightcove not-tgx=...
Source: TIME: Health - March 8, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Oncolytics Biotech (NASDAQ: ONCY) (TSX: ONC) Fights Cancer With Pelareorep, Which Has Received FDA Fast Track Designation For Breast And Pancreatic Cancer
A clinical-stage immunotherapeutics company focused on oncology with the goal of helping cancer patients live longer and healthier lives may be close to bringing therapy targeting multiple cancers to licensure-enabling studies. Reporting positive clinical and translational data in 2023, Oncolytics…#fda #oncolyticsbiotech #oncolytics #translational #sabcs #sitc #goblet #mattcoffey #pelareorep #clinicalgroup (Source: Reuters: Health)
Source: Reuters: Health - March 6, 2024 Category: Consumer Health News Source Type: news
